Hundreds of Sexual Enhancement Products Recalled Over Hidden Drug Ingredients

The FDA has found that several companies sold sexual enhancement products that contained prescription drug ingredients they never told customers about. Starting in March 2026, these companies issued recalls, pulling products off shelves after the FDA tested them and found pharmaceutical chemicals inside.

A company called Pure Vitamins and Natural Supplements recalled three products in March: Boner Bear Honey, Red Bull Extreme, and Blue Bull Extreme. All three contained hidden versions of sildenafil and tadalafil—the active ingredients in erectile dysfunction medications like Viagra and Cialis. Since then, at least six more companies have recalled their own products for the same reason.

What Products Are Affected

The recalls span many different product types sold through various stores and online. Gear Isle recalled chocolate sachets. JXK Enterprises pulled Boner Bears Chocolate. Lockout Supplements recalled a chocolate syrup. Even a distributor company called Nalpac recalled a product called DTF Sexual Chocolate, even though they didn't make it.

One company, Best Supplements Best Prices, recalled capsules that contained three hidden drugs at once: sildenafil, tadalafil, and flibanserin. Flibanserin is a prescription medication doctors prescribe specifically for women with low sexual desire.

Other recalls found a pain medication called diclofenac mixed into enhancement products, which is particularly concerning because that's a different class of drug altogether.

Why This Is Dangerous

If you take a hidden dose of sildenafil or tadalafil and you're also taking any heart medication containing nitrates (like nitroglycerin), your blood pressure can drop dangerously low. This combination can be fatal.

Flibanserin is especially risky when hidden in a product. It's a prescription drug because it requires medical supervision—doctors need to check that it's safe for each patient and monitor how they respond. If you buy it unlabeled in a supplement, you're bypassing that protection entirely. You don't know the right dose, and you won't know if it could hurt you based on your other medications or health conditions.

Diclofenac, the pain medication found in some recalls, can damage your stomach and increase your risk of blood clots. People buying these products as natural supplements would never expect that risk.

How Did This Happen

The FDA's findings suggest something is broken in how these products are made or sourced. Either multiple companies are buying contaminated ingredients from the same supplier, or the factories making them don't properly separate prescription drug ingredients from supplement ingredients—the way a kitchen wouldn't mix fish and peanuts if you had allergies.

Some of the companies doing the recalls didn't even make the products themselves. Nalpac, which distributes products to stores, recalled a product it didn't manufacture. This tells us the problem could be happening anywhere in the supply chain—during manufacturing, packaging, or distribution.

What Changed and What Comes Next

This isn't the first time the FDA has found hidden drugs in supplements. In 2020, the agency tested a product called U.S.A Viagra and found undisclosed sildenafil. But the 2026 wave is different—the FDA is catching many products at once, all in the same category, and some are contaminated with multiple drugs.

The speed and scale of these recalls suggest the FDA's lab testing has gotten better at detecting multiple hidden ingredients simultaneously. That's the good news: regulators are catching these products faster.

For companies selling sexual enhancement supplements, this is likely just the beginning. When the FDA identifies a problem product category, it typically increases testing in that area for months or years. Other companies making similar products should expect closer scrutiny ahead.

The bigger picture here is that dietary supplement companies—which operate in a less regulated space than pharmaceutical manufacturers—are not prepared for how sophisticated FDA testing has become. Many of these companies may not even know their suppliers are cutting in prescription drugs, but intent doesn't matter when customers face real health risks. Going forward, companies that can't guarantee their ingredients are pure will struggle to stay in business.